David Wu's background and AI path

In this episode, JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, speaks with David Wu, MD, PhD, and Adam Rodman, MD, MPH, about what safe clinical use of LLMs requires. Drawing on the framework of Do No Harm, they examine failure modes, limits of accuracy-based evaluation, clinician AI interaction, and safeguards needed as medical AI moves into patient care. Related Content:

• From AI Bench to AI Bedside